Metadata
- Name
- A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT02912949
- Description
- This is a Phase I/II, open-label, multi-center, multi-national, dose escalation, single agent
study to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of
zenocutuzumab (MCLA-128) in patients with solid tumors harboring an NRG1 fusion. - Data or Study Types
- clinical trial
- Keywords
- zenocutuzumab, Solid tumor, Non-small cell lung cancer, Pancreatic cancer, Bispecific Antibody IgG1, HER2, HER3, NSCLC, Antibodies, Bispecific, MCLA-128, Immunologic Factors, NRG1, NRG1 fusion, PDAC
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2016
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT02912949
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT02912949